Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor.

Item

http://www.wikidata.org/entity/Q42144353

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Cisplatin-DNA adduct formation ...... mal tissues and primary tumor.

@en

Cisplatin-DNA adduct formation ...... mal tissues and primary tumor.

@nl

type

Item

label

Cisplatin-DNA adduct formation ...... mal tissues and primary tumor.

@en

Cisplatin-DNA adduct formation ...... mal tissues and primary tumor.

@nl

prefLabel

Cisplatin-DNA adduct formation ...... mal tissues and primary tumor.

@en

Cisplatin-DNA adduct formation ...... mal tissues and primary tumor.

@nl

P1476

Cisplatin-DNA adduct formation ...... mal tissues and primary tumor.

@en

P2093

Balm AJ

http://www.w3.org/2001/XMLSchema#string

Bartelink H

http://www.w3.org/2001/XMLSchema#string

Begg AC

http://www.w3.org/2001/XMLSchema#string

Fons G

http://www.w3.org/2001/XMLSchema#string

Hart AA

http://www.w3.org/2001/XMLSchema#string

Hoebers FJ

http://www.w3.org/2001/XMLSchema#string

Pluim D

http://www.w3.org/2001/XMLSchema#string

Rasch CR

http://www.w3.org/2001/XMLSchema#string

Schellens JH

http://www.w3.org/2001/XMLSchema#string

Stalpers LJ

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Molecular profiling of platinum resistant ovarian cancer.

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.

32P-postlabeling assay for the quantification of the major platinum-DNA adducts.

Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.

P2888

s00280-007-0545-1

P304

1075-1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-007-0545-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6199973

http://www.w3.org/2001/XMLSchema#string

P6179

1050545104

http://www.w3.org/2001/XMLSchema#string

P698

17639394

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

2270367

http://www.w3.org/2001/XMLSchema#string